187 related articles for article (PubMed ID: 38225284)
1. Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels.
Çalık Başaran N; Dotan I; Dicker D
Int J Obes (Lond); 2024 Jan; ():. PubMed ID: 38225284
[TBL] [Abstract][Full Text] [Related]
2. Are the Changes in Gastrointestinal Hormone Secretion Necessary for the Success of Bariatric Surgery? A Critical Review of the Literature.
Lampropoulos C; Alexandrides T; Tsochatzis S; Kehagias D; Kehagias I
Obes Surg; 2021 Oct; 31(10):4575-4584. PubMed ID: 34304379
[TBL] [Abstract][Full Text] [Related]
3. Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis.
Tang T; Abbott S; le Roux CW; Wilson V; Singhal R; Bellary S; Tahrani AA
Diabetes Obes Metab; 2018 Mar; 20(3):745-748. PubMed ID: 29053203
[TBL] [Abstract][Full Text] [Related]
4. A Pilot Study Examining the Effects of GLP-1 Receptor Blockade Using Exendin-(9,39) on Gastric Emptying and Caloric Intake in Subjects With and Without Bariatric Surgery.
Kittah E; Camilleri M; Jensen MD; Vella A
Metab Syndr Relat Disord; 2020 Nov; 18(9):406-412. PubMed ID: 32833560
[No Abstract] [Full Text] [Related]
5. Distinct adaptations of endocrine and cognitive functions may contribute to high variability in long-term weight loss outcome after bariatric surgery.
Lammert M; Medawar E; Hartmann H; Grasser L; Dietrich A; Fenske W; Horstmann A
Physiol Behav; 2023 Oct; 269():114279. PubMed ID: 37356514
[TBL] [Abstract][Full Text] [Related]
6. Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Angelidi AM; Kokkinos A; Sanoudou D; Connelly MA; Alexandrou A; Mingrone G; Mantzoros CS
Metabolism; 2023 Jan; 138():155346. PubMed ID: 36375643
[TBL] [Abstract][Full Text] [Related]
7. Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial.
Yang J; Gao Z; Williams DB; Wang C; Lee S; Zhou X; Qiu P
Surg Obes Relat Dis; 2018 Oct; 14(10):1521-1529. PubMed ID: 30449509
[TBL] [Abstract][Full Text] [Related]
8. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
Rohde U
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
[TBL] [Abstract][Full Text] [Related]
9. The impact of glucagon-like peptide-1 receptor agonists (GLP-1 RA) on weight loss following bariatric treatment: a systematic review and meta-analysis.
Kramer CK; Retnakaran M; Viana LV
J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38488042
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profiles, energy expenditures, and body compositions of the weight regain versus sustained weight loss patients who underwent Roux-en-Y gastric bypass.
Shantavasinkul PC; Omotosho P; Muehlbauer MJ; Natoli M; Corsino L; Tong J; Portenier D; Torquati A
Surg Obes Relat Dis; 2021 Dec; 17(12):2015-2025. PubMed ID: 34635422
[TBL] [Abstract][Full Text] [Related]
11. A Meta-Analysis of GLP-1 After Roux-En-Y Gastric Bypass: Impact of Surgical Technique and Measurement Strategy.
Jirapinyo P; Jin DX; Qazi T; Mishra N; Thompson CC
Obes Surg; 2018 Mar; 28(3):615-626. PubMed ID: 28871519
[TBL] [Abstract][Full Text] [Related]
12. The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies.
Hindsø M; Svane MS; Hedbäck N; Holst JJ; Madsbad S; Bojsen-Møller KN
Surg Obes Relat Dis; 2021 Jul; 17(7):1383-1391. PubMed ID: 33771461
[TBL] [Abstract][Full Text] [Related]
13. What Is Best for Weight Loss? A Comparative Review of the Safety and Efficacy of Bariatric Surgery Versus Glucagon-Like Peptide-1 Analogue.
Klair N; Patel U; Saxena A; Patel D; Ayesha IE; Monson NR; Ramphall S
Cureus; 2023 Sep; 15(9):e46197. PubMed ID: 37905277
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin, glucagon-like peptide-1, and peptide YY secretion in patients with and without weight regain during long-term follow-up after bariatric surgery: a cross-sectional study.
Lampropoulos C; Mulita F; Alexandrides T; Kehagias D; Kalavrizioti D; Albanopoulos K; Georgopoulos N; Papachristou E; Kehagias I
Prz Menopauzalny; 2022 Jun; 21(2):97-105. PubMed ID: 36199737
[TBL] [Abstract][Full Text] [Related]
15. Weight Regain After Gastric Bypass: Influence of Gut Hormones.
Santo MA; Riccioppo D; Pajecki D; Kawamoto F; de Cleva R; Antonangelo L; Marçal L; Cecconello I
Obes Surg; 2016 May; 26(5):919-25. PubMed ID: 26450709
[TBL] [Abstract][Full Text] [Related]
16. Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it?
Smith EP; Polanco G; Yaqub A; Salehi M
Metabolism; 2018 Jun; 83():159-166. PubMed ID: 29113813
[TBL] [Abstract][Full Text] [Related]
17. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
[TBL] [Abstract][Full Text] [Related]
18. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
[TBL] [Abstract][Full Text] [Related]
19. Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
Papamargaritis D; le Roux CW
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652862
[TBL] [Abstract][Full Text] [Related]
20. The relation between postprandial glucagon-like peptide-1 release and insulin sensitivity before and after bariatric surgery in humans with class II/III obesity.
Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Romijn JA; Nieuwdorp M; Ter Horst KW; Serlie MJ
Surg Obes Relat Dis; 2021 Aug; 17(8):1440-1448. PubMed ID: 34083134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
